About
Aggamin develops an extracorporeal device to treat preeclampsia by reducing circulating pathogenic proteins to improve maternal and fetal health outcomes.
Explore Aggamin's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.